Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Autoinjectors Market to Grow from USD 127.30 Billion in 2026 to USD 300.46 Billion by 2031, at a CAGR of 18.7% – MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL, Aug. 10, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global autoinjectors market will grow from USD 127.30 billion in 2026 to USD 300.46 billion by 2031, at a CAGR of 18.7% during the forecast period.
Dr. Michael O’Brien to Serve IOC Fellowship at Steadman Philippon Research Institute
GlobeNewswire, Inc.
Vail, CO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI) welcomed its first visiting research fellow through a program SPRI supported in partnership with the International Olympic Committee (IOC). In December 2025,...
Rinn Pharma & Biopharma Expands European Research Collaboration Through NordicPharmaTrain Partnership
EIN Presswire
Rinn Pharma & Biopharma expanding collaborative research and training across the Nordic and European innovation landscape.
Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results
GlobeNewswire, Inc.
Press Release – No. 14 / 2026 Zealand Pharma conference call on August 13 at 2pm CEST (8am ET) to present second quarter 2026 financial results Copenhagen, Denmark, August 6, 2026 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
GlobeNewswire, Inc.
Enrollment complete in Phase 3 SONATA-HCM study; top-line data expected Q1 2027 NDA resubmission activities for ZYNQUISTA® in type 1 diabetes nearing completion Phase 1 clinical development of LX9851 ongoing by Novo Nordisk Conference call and...
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week
GlobeNewswire, Inc.
Early Outcomes Reinforce the Consistency and Reproducibility of Tanruprubart Treatment Effect Previously Demonstrated in Phase 3 and Real-World Evidence Studies Potential to Become the First Approved Targeted Therapy to Treat GBS Worldwide,...
Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities
GlobeNewswire, Inc.
Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities COPENHAGEN, Denmark, August 10 – Novonesis has signed an agreement with the intent to acquire MicroBioGen, an Australian biotechnology company with leading...
The 2026 Historic Hotels Worldwide® Annual Awards of Excellence Nominee Finalists are Announced
GlobeNewswire, Inc.
WASHINGTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Historic Hotels Worldwide® today announced its Nominee Finalists for the 2026 Historic Hotels Annual Awards of Excellence, recognizing the year’s best historic hotels and hospitality leaders from its...
H1 Partners with Novo Nordisk to Scale AI-Driven Clinical Development
GlobeNewswire, Inc.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- H1 today announced a new partnership with Novo Nordisk to improve clinical development in the age of AI. The partnership aims to develop proprietary AI-ready data and AI-powered clinical development...
Randomized U.S. Trial Finds Autonomous System Improves Precision of Hospital Oxygen Therapy
GlobeNewswire, Inc.
Copenhagen, Denmark, Aug. 03, 2026 (GLOBE NEWSWIRE) -- — O2matic ApS today announced results from a randomized, multicenter U.S. clinical trial showing that hospitalized patients receiving autonomous oxygen titration with the O2matic PRO 100 spent...
Zealand Pharma - Transactions related to share buy-back program (week 31, 2026)
GlobeNewswire, Inc.
Company announcement No. 36 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 31, 2026) Copenhagen, Denmark, August 3, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
NRG Therapeutics Announces the Appointment of Claus Sundgreen M.D. as Chief Medical Officer
GlobeNewswire, Inc.
STEVENAGE, United Kingdom, Aug. 03, 2026 (GLOBE NEWSWIRE) -- NRG Therapeutics Ltd. (“NRG”), a clinical stage neuroscience company developing novel disease-modifying therapeutics that rectify mitochondrial dysfunction in neurodegenerative diseases,...
Final ASTRUM-002 Analysis Shows Survival Benefit with Hetronifly in Advanced nsqNSCLC After Four Years of Follow-Up
EIN Presswire
SHANGHAI, CHINA, August 10, 2026 /EINPresswire.com/ -- Shanghai Henlius Biotech, Inc. (2696.HK), headquartered in Shanghai and listed on the Hong Kong Stock Exchange, recently announced definitive final survival findings from its proprietary...
BioAgeDiagnostics Strengthens Global Medical Advisory Board with Dr. Stuart M. Diamond
EIN Presswire
Board-certified longevity physician and surgeon joins BioAgeDiagnostics to accelerate the global adoption of precision longevity diagnostics.
Zealand Pharma - Transactions related to share buy-back program (week 30, 2026)
GlobeNewswire, Inc.
Company announcement No. 35 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 30, 2026) Copenhagen, Denmark, July 27, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
GlobeNewswire, Inc.
New publication identifies neuromuscular junction transmission failure as a novel mechanism contributing to sarcopenia, with preclinical studies showing that ClC-1 inhibition improves neuromuscular transmission and muscle function NMD Pharma is...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire, Inc.
Company announcement – No. 34 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S...
Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
GlobeNewswire, Inc.
Company announcement No. 33 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 29, 2026) Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
GlobeNewswire, Inc.
STAFFORD, Texas, July 20, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
Alpine Psychiatry Offers Comprehensive Mental Health Services Across Pennsylvania
EIN Presswire
Clinician-owned practice provides in-person and virtual psychiatric care and therapy to patients across Pennsylvania, New Jersey, and New York. KING OF PRUSSIA, PA, UNITED STATES, July 16, 2026 /EINPresswire.com/ -- Alpine Psychiatry, a...
Sign up for:
Healthcare Times Denmark
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.